Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
PMVP
$1.39
+10.76%
PMVP
· PMV Pharmaceuticals, Inc.
$1.39
+0.14 (+10.76%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has determined that the Company's current available cash, cash equivalents and marketable securities may not be sufficient to fund its planned operations for at least one year from the date of this Quarterly Report, and there is substantial doubt as to the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$74.31M
Shares
53.46M
Volume · Oct 20
347.58K
Avg daily vol (3M)
658.75K
All webcasts
Earnings call · FY2024 Q2
PMV Pharmaceuticals, Inc. (PMVP) Q2 2024 Earnings Call
Diluted EPS
-$0.02
Net income
-$1.21M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 8, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 8, 2024 · complete as-filed document